Ubs Asset Management Americas Inc Eq Rx, Inc. Transaction History

Ubs Asset Management Americas Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.31 $167,261 - $232,755	100,760 Added 61.79%	263,821 $585,000
Q1 2023 May 15, 2023	BUY	$1.8 - $2.83 $2,662 - $4,185	1,479 Added 0.92%	163,061 $316,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $43,531 - $116,792	21,235 Added 15.13%	161,582 $397,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $5.99 $7,694 - $49,034	-8,186 Reduced 5.51%	140,347 $694,000
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.69 $475,305 - $845,152	148,533 New	148,533 $696,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.